Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+208.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+208.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
29.2x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 257.38% |
| 2023 | 5.07% |
| 2022 | -26.97% |
| 2021 | 8.80% |
| 2020 | -72.13% |
| 2019 | -15.77% |
| 2018 | -114.94% |
| 2017 | -71.42% |
| 2016 | -14.07% |
| 2015 | -9.59% |